Is Genetic Medicine Making the World Less Fair?
By Laura Hercher,
The Nation
| 08. 23. 2019
New reproductive technologies promise to prevent serious genetic disease. What happens if only the rich can access them?
Call it the “ick” factor.
Stories like the 2018 bombshell out of China, of a scientist manipulating embryonic DNA to produce the world’s first genetically engineered human babies, make people uneasy, often in ways they find hard to define. Our fear of genetics is diffuse and visceral and surfaces in a range of dystopian visions, from experiments gone wrong, à la Frankenstein’s monster, to worlds dominated by genetically enriched super-people. But while our antennae are attuned to things distant, scary and futuristic, we may be missing the more real and immediate threat: Genetic medicine as we practice it today is poised to alter our concept of disease and responsibility in ways that will make the world fundamentally more unfair.
If you could use reproductive genetic technology to make sure that your child did not have a genetic disease, would you do it? That question is not science fiction anymore for many prospective parents. If you have an increased risk of breast and ovarian cancer because of a variant in your genes, there are now ways to make sure you...
Related Articles
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...